Two-Hour test could curb superbug spread in hospitals
NCT ID NCT07663110
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to see if a rapid 2-hour test for carbapenem-resistant bacteria (CPE) can reduce person-to-person spread in hospitals better than the standard 24-hour test. Researchers will screen 16,000 adult patients admitted to hospital and track who carries CPE. They will also analyze costs to see if the faster test is worth adopting widely.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster screening strategies that reduce the spread of drug-resistant bacteria in hospitals and save healthcare costs.
- What could go wrong
- This is an observational study, not a treatment trial. The faster test may not significantly reduce transmission, and results may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 16,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All adult (18 years or older) medical patients admitted to the acute medical unit during the implementation period who undergo routine rectal CPE testing as per local Trust policy and test positive for CPE colonisation through either the rapid test or culture-based methods. Exclusion Criteria: * Patient refusal for rectal screening or * Clinical contraindication to rectal swab collection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carbapenem-resistant enterobacteriaceae are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Charing Cross Hospital
London, United Kingdom
-
St Thomas' hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.